Back to Search Start Over

Anticoagulation may be beneficial in high risk factor V Leiden carriers.

Authors :
Baglin T
Baglin C
Brown K
Luddington R
Source :
BMJ (Clinical research ed.) [BMJ] 1998 Aug 08; Vol. 317 (7155), pp. 416.
Publication Year :
1998

Subjects

Subjects :
Cohort Studies
Heterozygote
Humans
Prospective Studies
Recurrence
Thrombophlebitis drug therapy
Anticoagulants therapeutic use
Factor V genetics
Warfarin therapeutic use

Details

Language :
English
ISSN :
0959-8138
Volume :
317
Issue :
7155
Database :
MEDLINE
Journal :
BMJ (Clinical research ed.)
Publication Type :
Editorial & Opinion
Accession number :
9694774

Tools

Authors Abstract Subjects Details